SEARCH

SEARCH BY CITATION

References

  • Ballarin M., Fredholm B. B., Ambrosio S. and Mahy N. (1991) Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand. 142, 97103.
  • Borycz J., Pereira M. F., Melani A., Rodrigues R. J., Kofalvi A., Panlilio L., Pedata F., Goldberg S. R., Cunha R. A. and Ferre S. (2007) Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. J. Neurochem. 101, 355363.
  • Ciruela F., Casado V., Rodrigues R. J. et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 20802087.
  • Cunha R. A. (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38, 107125.
  • Cunha R. A. (2005) Neuroprotection by adenosine in brain: from A1 receptor activation to A2A receptor blockage. Purinergic Signal. 1, 111134.
  • Cunha R. A., Vizi E. S., Riberio J. A. and Sebastiao A. M. (1996) Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation. J. Neurochem. 67, 21802187.
  • Dale N. (1998) Delayed production of adenosine underlies temporal modulation of swimming in frog embryo. J. Physiol. 511, 265272.
  • Dale N., Pearson T. and Frenguelli B. G. (2000) Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol. 526, 143155.
  • Dale N., Gourine A. V., Llaudet E., Bulmer D., Thomas T. and Spyer K. M. (2002) Rapid adenosine release in the nucleus tractus solitarii during defence response in rats: real-time measurement in vivo. J. Physiol. 544, 149160.
  • Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P. and Williams M. (1994) Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143156.
  • Fredholm B. B., IJzerman A. P., Jacobson K. A., Klotz K. N. and Linden J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527552.
  • Frenguelli B. G., Wigmore G., Llaudet E. and Dale N. (2007) Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J. Neurochem. 101, 14001413.
  • Fuxe K., Ferre S., Zoli M. and Agnati L. F. (1998) Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res. Brain Res. Rev. 26, 258273.
  • Grabb M. C., Sciotti V. M., Gidday J. M., Cohen S. A. and Van Wylen D. G. (1998) Neurochemical and morphological responses to acutely and chronically implanted brain microdialysis probes. J. Neurosci. Methods 82, 2534.
  • Heien M. L. A. V., Phillips P. E. M., Stuber G. D., Seipel A. T. and Wightman R. M. (2003) Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst 128, 14131419.
  • Hitchman M. L. (1978) Measurements of Dissolved Oxygen. John Wiley & Sons, New York.
  • Ito C. (2000) The role of brain histamine in acute and chronic stresses. Biomed. Pharmacother. 54, 263267.
  • Jarvis M. F., Yu H., Kohlhaas K., Alexander K., Lee C. H., Jiang M., Bhagwat S. S., Williams M. and Kowaluk E. A. (2000) ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. J. Pharmacol. Exp. Ther. 295, 11561164.
  • Kowaluk E. A., Mikusa J., Wismer C. T. et al. (2000) ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J. Pharmacol. Exp. Ther. 295, 11651174.
  • Latini S. and Pedata F. (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463484.
  • Llaudet E., Botting N. P., Crayston J. A. and Dale N. (2003) A three-enzyme microelectrode sensor for detecting purine release from central nervous system. Biosens. Bioelectron. 18, 4352.
  • Lloyd H. G., Lindstrom K. and Fredholm B. B. (1993) Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int. 23, 173185.
  • Lowry J. P., Boutelle M. G. and Fillenz M. (1997) Measurement of brain tissue oxygen at a carbon paste electrode can serve as an index of increases in regional cerebral blood flow. J. Neurosci. Methods 71, 177182.
  • McGaraughty S., Cowart M. and Jarvis M. F. (2001) Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential. CNS. Drug Rev. 7, 415432.
  • Michael D., Travis E. R. and Wightman R. M. (1998) Color images for fast-scan CV measurements in biological systems. Anal. Chem. 70, 586A592A.
  • Ngai A. C., Coyne E. F., Meno J. R., West G. A. and Winn H. R. (2001) Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. Am. J. Physiol. Heart Circ. Physiol 280, H2329H2335.
  • Noji T., Karasawa A. and Kusaka H. (2004) Adenosine uptake inhibitors. Eur. J. Pharmacol. 495, 116.
  • O’Regan M. (2005) Adenosine and the regulation of cerebral blood flow. Neurol. Res. 27, 175181.
  • Parkinson F. E., Paterson A. R., Young J. D. and Cass C. E. (1993) Inhibitory effects of propentofylline on [3H]adenosine influx. A study of three nucleoside transport systems. Biochem. Pharmacol. 46, 891896.
  • Parkinson F. E., Rudolphi K. A. and Fredholm B. B. (1994) Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen. Pharmacol. 25, 10531058.
  • Paxinos G. and Watson C. (2005) The Rat Brain in Stereotaxic Coordinates. Elsevier Academic Press, San Diego.
  • Pazzagli M., Corsi C., Fratti S., Pedata F. and Pepeu G. (1995) Regulation of extracellular adenosine levels in the striatum of aging rats. Brain Res. 684, 103106.
  • Pedata F., Pazzagli M., Tilli S. and Pepeu G. (1990) Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices. Naunyn Schmiedebergs Arch. Pharmacol. 342, 447453.
  • Peters J. L., Miner L. H., Michael A. C. and Sesack S. R. (2004) Ultrastructure at carbon fiber microelectrode implantation sites after acute voltammetric measurements in the striatum of anesthetized rats. J. Neurosci. Methods 137, 923.
  • Phillis J. W. (1989) Adenosine in the control of the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1, 2654.
  • Radek R. J., Decker M. W. and Jarvis M. F. (2004) The adenosine kinase inhibitor ABT-702 augments EEG slow waves in rats. Brain Res. 1026, 7483.
  • Robinson D. L., Heien M. L. and Wightman R. M. (2002) Frequency of dopamine concentration transients increases in dorsal and ventral striatum of male rats during introduction of conspecifics. J. Neurosci. 22, 1047710486.
  • Sciotti V. M. and Van Wylen D. G. (1993) Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase. J. Cereb. Blood Flow Metab. 13, 201207.
  • Sciotti V. M., Park T. S., Berne R. M. and Van Wylen D. G. (1993) Changes in extracellular adenosine during chemical or electrical brain stimulation. Brain Res. 613, 1620.
  • Swamy B. E. and Venton B. J. (2007) Subsecond detection of physiological adenosine concentrations using fast-scan cyclic voltammetry. Anal. Chem. 79, 744750.
  • Sweeney M. I. (1997) Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci. Biobehav. Rev. 21, 207217.
  • Thorn J. A. and Jarvis S. M. (1996) Adenosine transporters. Gen. Pharmacol. 27, 613620.
  • Turcani P. and Turcani M. (2001) Effect of propentofylline on cerebral blood flow in a gerbil focal cerebral ischemia. J. Neurol. Sci. 183, 5760.
  • Venton B. J., Michael D. J. and Wightman R. M. (2003a) Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J. Neurochem. 84, 373381.
  • Venton B. J., Zhang H., Garris P. A., Phillips P. E. M., Sulzer D. and Wightman R. M. (2003b) Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J. Neurochem. 87, 12841295.
  • Winn H. R., Rubio G. R. and Berne R. M. (1981) The role of adenosine in the regulation of cerebral blood flow. J. Cereb. Blood Flow Metab. 1, 239244.
  • Yoshimatsu H., Chiba S., Tajima D., Akehi Y. and Sakata T. (2002) Histidine suppresses food intake through its conversion into neuronal histamine. Exp. Biol. Med. (Maywood.) 227, 6368.
  • Zimmerman J. B. and Wightman R. M. (1991) Simultaneous electrochemical measurements of oxygen and dopamine in vivo. Anal. Chem. 63, 2428.